Laboratory Chemicals Market

In 2021, the global market for laboratory chemicals was valued at US$20.66 billion and is expected to grow at a rate of 6.5% to US$34.19 billion by 2029.

Market Overview

Laboratory chemicals, also called reagents, are used in lab settings for scientific research, analysis and experimentation. These chemicals are important for many industries - from pharmaceuticals and biotech to environmental analysis and even food and beverages.

These chemicals are used for testing, quality control, sample preparation, and as components in lab procedures and experiments.

Some of the most common processes that use laboratory chemicals contain carboxylation, acid chloride preparations, and ion-exchange reactions, among other such reactions. These chemicals, therefore, play a major role in the production of a variety of market products.

The laboratory chemicals market is segmented using three main criteria:

• Product: Biochemistry, carbohydrate analysis, cell/tissue culture, cytokine and chemokine testing, environmental testing, molecular biology
• Application: Education, government, healthcare, industrial
• End user: Academics, biotechnology, corporate industries, non-academics

Key Findings:

• The value of the laboratory chemicals market in 2021 was $20.66 billion
• The projected CAGR for the market is 6.5% over the forecasted period (2021-2029)
• The expected value by the end of the forecast period is $34.19 billion
• The corporate industry end user segment has the biggest market share and is likely to remain as such over the forecast period
• The cytokine and chemokine segment is the largest by product type
• The North American market has the largest share
• The Asia Pacific market is the fastest growing
• The market is driven mainly by the focus on R&D, advancements in technology, and growth in the healthcare sector, where these chemicals are needed for testing.
• The major market constraints are the complexity of the supply chain, as well as the price volatility
• Opportunities for the laboratory chemicals market lie in emerging markets and the increased focus on green and sustainable processes.

Market Drivers

Increase in R&D Activities

The continuous emphasis on innovation and advancements in scientific research across industries drives the demand for laboratory chemicals.

R&D activities in pharmaceuticals, biotechnology, healthcare, and other sectors rely heavily on laboratory chemicals for experimentation, testing, and analysis. The work towards new discoveries, improved processes, and the development of new products fuels the demand for a wide range of laboratory chemicals.

Advancements in Technology & Automation

Technological advancements in laboratory equipment and automation have significantly impacted the laboratory chemicals market.

The adoption of automated systems, high-throughput screening methods, and the use of robotics in laboratories has increased the demand for specialized chemicals and reagents that cater to these advanced technologies.

The need for accuracy, precision, and efficiency in laboratory processes also drives the requirement for specific chemicals designed for these applications.

Demand for Specialized Applications

The increasing demand for specialized laboratory chemicals tailored for specific applications and research areas is a notable market driver.

As scientific fields such as genomics, proteomics, metabolomics, and nanotechnology continue to advance, the need for specialized chemicals and reagents that meet specific requirements grows. The development and availability of these specialized chemicals cater to the evolving needs of researchers in these fields.

Growing Healthcare Sector

The expanding healthcare industry, driven by factors such as an aging population, increasing prevalence of diseases, and advancements in medical treatments, significantly influences the demand for laboratory chemicals.

These chemicals play a critical role in diagnostic testing, drug development, and personalized medicine. The demand for laboratory chemicals in the healthcare sector is expected to continue growing as healthcare providers strive for more accurate and reliable analytical results.

Due to the sensitive nature of healthcare processes, there is great importance placed on these factors, and thus, the use and demand of laboratory chemicals grow.

Market Opportunities

Emerging Markets

Developing economies, particularly in highly populated regions like Asia-Pacific, Latin America, and Africa, offer significant growth opportunities for the laboratory chemicals market. These regions are experiencing rapid industrialization, increasing investments in healthcare infrastructure, and a growing focus on research and development.

As the demand for laboratory testing, quality control, and scientific advancements rises in these markets, the need for laboratory chemicals also expands. Manufacturers can tap into these emerging markets by establishing strategic partnerships, distribution networks, and localized production facilities. This will drive market growth further.

Green Chemistry Initiatives

The increasing emphasis on environmental sustainability and green practices opens doors for manufacturers to develop and promote eco-friendly laboratory chemicals.

Manufacturers can seize this opportunity by offering sustainable alternatives, greener formulations, and environmentally friendly packaging. Positioning themselves as environmentally conscious providers of laboratory chemicals can attract environmentally-minded customers and align with their sustainability goals.

Market Challenges

Volatility in Raw Material Prices

The laboratory chemicals market is influenced by the volatility in raw material prices. Many laboratory chemicals are derived from petroleum-based feedstocks, and fluctuations in oil prices can impact the cost of production.

Unpredictable price variations can make it challenging for manufacturers to maintain consistent pricing and profitability. Disruptions in the supply chain or scarcity of raw materials can further disrupt production and increase costs.

Cost Constraints

Cost considerations can act as a restraint for the laboratory chemicals market. Some specialized laboratory chemicals can be expensive, making them less accessible to smaller laboratories or institutions with limited budgets.

Cost constraints can limit the adoption of certain chemicals, hinder research and development activities, and impact the overall market growth.

Complex Supply Chain

The laboratory chemicals market relies on a complex global supply chain. Factors such as transportation challenges, geopolitical issues, and disruptions in the supply chain can impact the availability, pricing, and timely delivery of laboratory chemicals.

Reliance on raw material suppliers, logistics providers, and distributors can introduce complexities and vulnerabilities, affecting the smooth operation of the market.

Intense Competition

The laboratory chemicals market is highly competitive, with numerous players vying for market share. Manufacturers face competition from both established companies and new entrants. Differentiation based on product quality, customization, customer service, and innovation is crucial for success.

Competitive pressures can impact pricing dynamics and profitability for manufacturers in the laboratory chemicals market.

Regional Coverage

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

North America is the largest market share as of 2022, and is likely to stay that way over the forecast period. The Asia Pacific market is the fastest growing, propelled by the growing economies in China and India. China is currently one of the largest markets for the chemical industry in the world.

Company Recent Development 

The major players in the industry are:

1. Avantor Inc.
2. Merck
3. Takara Bio Inc.
4. Sinopharm
5. Shimadzu Biotech
6. GE Healthcare
7. Lonza Biologics Ltd.
8. BioMerieux
9. Aladdin
10. Beckman Coulter Inc.
11. BD Biosciences
12. EMD Chemicals
13. Meridian Life Sciences Inc.

In 2021, Merck purchased Cord Therapeutics, a Swedish company. This enables Merck to focus on developing cladribine, which is used to treat neurological diseases.

In 2021, GE Healthcare introduced its new molecular imaging products. This implies innovation in diagnostics and radiology and increased access to these procedures.